Amarin Corp Plc (AMRN)

[concapk]

CAL:

You're missing the whole point of the court's decision..... the GENERICS were trying to invalidate AMARIN'S PATENT by ( WRITTEN DESCRIPTION ) thus allowing generics to sell an identical drug to VASCEPA.....

This decision today eliminated the generics winning on Infringement, with the other three areas being moot...

What the GENERICS might have won today is to sell a drug for HIGH TRI'S,over 500 ... the same as AMARIN, but their label will only say "HIGH TRIG'S " that it... They CANNOT SAY their drug reduces cardiovascular disease or any other indications that AMARIN files for... court did not allow GENERICS to ever claim OTHER HEALTH BENEFITS on label...

This is a big win for AMARIN..... The GENERICS should settle and wait for patent expiration....